📌 Key Takeaways
- Topic: Precipitated Silica Manufacturer: Production Process and Supplier Selection Guide
- Keywords: Aerosil R972
- Published: 2026-11-20 03:10:30
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
What Is Tetraethyl Orthosilicate? Properties, Uses and Role in Silica Synthesis
- Glass Beads vs Silica Microspheres: Differences and Uses
- What Is E551? Silicon Dioxide as a Food Additive, Uses and Safety
- Silica Nanopowder: Particle Size, Specifications and Industrial Uses
- Magnetic particles were synthesized with an iron-containing coating. The model drugs were safranin O and hydrocortisone. The particles were functionalized with a bulky azo derivative to act as a gatekeeper and stop early leakage of the drug. In vitro release models have demonstrated that most of the drug is released only in the colon, as desired. This is owing to the reductive environment in the colon (the presence of the azoreductase enzyme), where the enzymatic degradation of the azo bond resulted in controlled release. In addition, in vivo pharmacokinetic studies were conducted in a rat model of induced colitis to test the effect of the magnetic field during therapy. The findings boosted when the rats wore a magnetic belt, which extended the retention time of the particles in the desired areas [ 75 ]. Zhang et al. presented a study in which magnetic silica nanoparticles (filled with sulforaphane) were developed for the treatment of myocardial infarction [ 38 ]. In mouse models, effective accumulation was observed in the infarcted zone after the application of an external magnetic field [ 33, 75 ]. These results show the potential of using magnetic particles with magnetic field guidance [ 33 ]. Radhakrishnan et al. developed a drug delivery system (DDS) loaded with carboplatin for targeted lung cancer therapy [ 63 ]. The DDS was core-shell mesoporous silica functionalized with folic acid. Initially, the drug loading capability of the functionalized carrier was more than twice as high per surface unit compared to the non-functionalized carrier due to the anchored -NH 2 groups. The drug release was sustained but limited (up to 36%) in the case of the functionalized particle, similarly to previous cases. This is most likely owing to the stronger interactions between the amine groups and the carboplatin. The amino-functionalized particles were further functionalized with folic acid to increase cellular uptake of the particles, demonstrating the potential of folic acid-targeted therapy [ 63, 65, 76 ]. Cancer cells typically overexpress folate receptors, resulting in folate-mediated internalization that preferentially targets these cells [ 63, 76 ]. This was demonstrated in a drug-mediated cytotoxicity analysis where amino- and folate-functionalized particles were evaluated and compared. Much greater cytotoxicity was observed in cells overexpressing folate receptors [ 63 ]. Similar research was carried out by Shirani et al., where folic acid functionalized MSNs were loaded with gemcitabine as a model drug, to investigate its potential in cancer treatment, while actively targeting cancer cells [ 70 ]. Outcomes have shown that higher cellular uptake (HeLa and K562 cells) was observed in the case of the functionalized particles, compared with the non-functionalized carriers [ 70 ]. Jafarpour et al. demonstrated the importance of functionalizing the carriers to accomplish targeted therapy utilizing methotrexate as a model drug [ 76 ]. The particles were grafted with a copolymer to act as a pH-responsive gatekeeper and folic acid to actively target cancer cells [ 76 ]. Ortiz et al. similarly designed a pH-responsive DDS, loaded with the anticancer drug doxorubicin [ 11 ]. The particles were functionalized with transferrin through a pH-sensitive linker as a gatekeeper, controlling the release kinetics and preventing early leakage of the drug [ 11 ]. An interesting breast cancer therapy was published by Mal et al. using doxorubicin as API and mesoporous silica as a carrier [ 65 ]. The amine-functionalized MSNs were PEGylated and then conjugated with folic acid or hyaluronic acid. It was also published that coating the nanoparticles with polydopamine (PDA) and polyethylene glycol (PEG) brings about prolonged doxorubicin release from MSNs [ 77 ]. These conjugates enabled ligand-mediated targeted drug delivery [ 65 ]. Researchers have developed a successful DDS that targets cancer cells, thus staying away from the side effects associated with doxorubicin in conventional cancer therapy. This is important because in vitro cytotoxicity studies have shown that the free drug has higher cytotoxicity than the nanocarriers [ 65 ]. Shahbaz et al. developed a redox-responsive silica nanocarrier loaded with paclitaxel to target breast cancer cells [ 67 ]. The amine-functionalized silica core was coated with disulfide-functionalized non-porous silica shell. Then the core-shell carriers were further coated with polyethylene glycol via disulfide linkages. In vitro drug release assay verified the correlation between the redox potential of the environment and the release kinetics. This is an important finding, as it has been revealed that cancer cells possess a higher redox ability than healthy cells. This provides controlled paclitaxel release for targeted therapy. According to cell uptake and cell viability assays, this DDS is noticeably more effective than free paclitaxel, making this nanocarrier an exciting prospect [ 67 ]. These illustrations highlight the importance of surface functionalization and employing stimuli-responsive gatekeepers to attain productive targeted therapy.
- Mica Powder vs Silica: Properties and Applications Compared
- The carriers can have ordered and disordered pore structures [ 1, 2 ]. The ordered mesopores have a regular, homogeneous pore structure and a tunable internal frame, which permits the optimization of the API formulation, while the disordered ones have a random distribution of pore structure. Pores can be divided into two chief groups according to their geometry. There are open and closed pores, based on whether the pore is accessible to the medium or not. In the case of open pores, further differentiation is also possible. Blind pores are only accessible from one direction, while through pores are accessible from at least two directions [ 3 ]. The arrangement of the pores can also be defined and changed, hence the kinetics and dynamics of the release of the API can be influenced and regulated [ 1 ]. Laminar (tubular), radial, hexagonal, or cubic arrangements can also be created [ 1 ]. It is well known that the pore size significantly affects drug loading and drug release [ 1, 3 ]. Nonetheless, the literature is not crystal clear regarding correlation [ 14 ]. Some studies show proof that larger pores provide faster drug release [ 15, 16, 26 ], and larger pores have demonstrated a faster degradation rate in the lymph nodes [ 15 ], and reports limited release for smaller pores as they limit the diffusion process, which is called the steric hindrance influence [ 16, 26 ]. Nevertheless, in other publications, proof recommends that larger pores facilitate slower drug release, as the drug is loaded and trapped in deeper channels, requiring a longer access time for the release medium [ 14 ]. In general, the adsorption capacity can indeed be increased by increasing the specific surface area of the carrier and by decreasing the pore diameter [ 17 ].
What Is Silica Sand? Composition, Grades, Mesh Sizes and Industrial Uses
What is silica (SiO₂)?
talc powder
What is the difference between fumed silica and precipitated silica?
silica for rubber This equation fits especially well for premature release, up to 60% of the drug released, when there is no change in the matrix system during the release process. From a perspective of pore geometry, it basically controls drug release rates by affecting effective diffusion pathways. Boosted complexity of geometries raises tortuosity and reduces effective diffusion. High tortuosity and low pore connectivity cut down drug diffusion, consequently lowering the release rates. Furthermore, surface roughness and pore size distribution affect surface region, diffusion, and residence times, and thereby drug release kinetics. Thus, coupling the Fick diffusion model with parameters characterizing pore geometry (e.g., porosity, tortuosity, etc.) enables for more precise and automatic modeling of drug release kinetics. In this way, it is nicely clarified why release profiles differ for chemically comparable matrices due to differences in their geometrical shapes [ 59, 60 ].
What drives silica raw material prices?
silica OEM
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.